Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Kappelman and Manasi Agrawal.
Michael Kappelman
Connection Strength
2.664
Manasi Agrawal
  1. COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol. 2021 10; 19(10):2210-2213.e3.
    View in: PubMed
    Score: 0.949
  2. Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry. Inflamm Bowel Dis. 2021 03 15; 27(4):585-589.
    View in: PubMed
    Score: 0.934
  3. The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry. J Crohns Colitis. 2021 Nov 08; 15(11):1877-1884.
    View in: PubMed
    Score: 0.244
  4. Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2021 Jun 28.
    View in: PubMed
    Score: 0.238
  5. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry. J Crohns Colitis. 2021 May 04; 15(5):860-863.
    View in: PubMed
    Score: 0.236
  6. New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry. Inflamm Bowel Dis. 2022 02 01; 28(2):314-317.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.